Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis

International Immunology

Volumn 15, Issue 8, 2003, Pages 915-925

  Dascher, Christopher C ^a   Hiromatsu, Kenji ^b   Xiong, Xiaowei ^a   Morehouse, Caroline ^a   Watts, Gerald ^a   Liu, Gui ^c   McMurray, David N ^d   LeClair, Kenneth P ^c   Porcelli, Steven A ^b   Brenner, Michael B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Antigenics Inc   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Bacterial infection; Lung; Rodent; Vaccination

Indexed keywords

ADJUVANT; BACTERIAL ANTIGEN; BCG VACCINE; CD1 ANTIGEN; DRUG VEHICLE; GLYCOLIPID; LIPID; LIPOSOME; MYCOBACTERIUM VACCINE; SUBUNIT VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; DRUG FORMULATION; FEMALE; GUINEA PIG; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOGENICITY; LUNG GRANULOMA; LUNG TUBERCULOSIS; MORPHOMETRICS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPLEEN; T LYMPHOCYTE; TISSUE NECROSIS; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INHALATION; ANIMALS; ANTIGENS, CD1; DISEASE MODELS, ANIMAL; FEMALE; GLYCOLIPIDS; GRANULOMA; GUINEA PIGS; HISTOCYTOCHEMISTRY; LIPIDS; LIPOSOMES; LUNG; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; QUATERNARY AMMONIUM COMPOUNDS; SAPONINS; SPLEEN; TUBERCULOSIS, PULMONARY; VACCINES;

EID: 12444315075     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg091     Document Type: Review

References (44)

1. Dye, C., Scheele, S., Dolin, P., Pathania, V. and Raviglione, M. C. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. J. Am. Med. Ass. 282:677.
2. Crispen, R. 1989. History of BCG and its substrains. Prog. Clin. Biol. Res. 310:35.
3. Moore, D. F. 1983. The history and development of the BCG. Practitioner 227:i-iii.
4. Orme, I. M. 1999. Beyond BCG: the potential for a more effective TB vaccine. Mol. Med. Today 5:487.
5. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B. and Bloom, B. R. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl Acad. Sci. USA 89:12013.
6. Mogues, T., Goodrich, M. E., Ryan, L., LaCourse, R. and North, R. J. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271.
7. Porcelli, S. A. 1995. The CD1 family: a third lineage of antigen-presenting molecules. Adv. Immunol. 59:1.
8. + T cells. Nature 372:691.
9. Sieling, P. A., Chatterjee, D., Porcelli, S. A., Prigozy, T. I., Mazzaccaro, R. J., Soriano, T., Bloom, B. R., Brenner, M. B., Kronenberg, M., Brennan, P. J., et al. 1995. CD1-restricted T cell recognition of microbial lipoglycan antigens. Science 269:227.
10. Moody, D. B., Reinhold, B. B., Guy, M. R., Beckman, E. M., Frederique, D. E., Furlong, S. T., Ye, S., Reinhold, V. N., Sieling, P.A., Modlin, R. L., Besra, G. S. and Porcelli, S. A. 1997. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 278:283.
11. Moody, D. B., Ulrichs, T., Muhlecker, W., Young, D. C., Gurcha, S. S., Grant, E., Rosat, J. P., Brenner, M. B., Costello, C. E., Besra, G. S. and Porcelli, S. A. 2000. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature 404:884.
12. Gumperz, J. E., Roy, C., Makowska, A., Lum, D., Sugita, M., Podrebarac, T., Koezuka, Y., Porcelli, S. A., Cardell, S., Brenner, M. B. and Behar, S. M. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity 12:211.
13. Kawano, T., Cui, J., Koezuka, Y., Toura, I., Kaneko, Y., Motoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E., Koseki, H. and Taniguchi, M. 1997. CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278:1626.
14. - T lymphocytes to a microbial antigen. Nature 360:593.
15. Stenger, S., Mazzaccaro, R. J., Uyemura, K., Cho, S., Barnes, P. F., Rosat, J. P., Sette, A., Brenner, M. B., Porcelli, S. A., Bloom, B. R. and Modlin, R. L. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684.
16. Calabi, F., Jarvis, J. M., Martin, L. and Milstein, C. 1989. Two classes of CD1 genes. Eur. J. Immunol. 19:285.
17. Gumperz, J. E. and Brenner, M. B. 2001. CD1-specific T cells in microbial immunity. Curr. Opin. Immunol. 13:471.
18. Bradbury, A., Belt, K. T., Neri, T. M., Milstein, C. and Calabi, F. 1988. Mouse CD1 is distinct from and co-exists with TL in the same thymus. EMBO J. 7:3081.
19. Dascher, C. C., Hiromatsu, K., Naylor, J. W., Brauer, P. P., Brown, K. A., Storey, J. R., Behar, S. M., Kawasaki, E. S., Porcelli, S. A., Brenner, M. B. and LeClair, K. P. 1999. Conservation of a CD1 multigene family in the guinea pig. J. Immunol. 163:5478.
20. Hiromatsu, K., Dascher, C. C., Sugita, M., Gingrich-Baker, C., Behar, S. M., LeClair, K. P., Brenner, M. B. and Porcelli, S. A. 2002. Characterization of guinea-pig group 1 CD1 proteins. Immunology 106:159.
21. Horwitz, M. A., Harth, G., Dillon, B. J. and Maslesa-Galic, S. 2000. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc. Natl Acad. Sci. USA 97:13853.
22. Horwitz, M. A., Lee, B. W., Dillon, B. J. and Harth, G. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 92:1530.
23. Baldwin, S. L., D'Souza, C., Roberts, A. D., Kelly, B. P., Frank, A. A., Lui, M. A., Ulmer, J. B., Huygen, K., McMurray, D. M. and Orme, I. M. 1998. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect. Immun. 66:2951.
24. Smith, D., Harding, G., Chan, J., Edwards, M., Hank, J., Muller, D. and Sobhi, F. 1979. Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs. J. Biol. Stand. 7:179.
25. Williams, A., Davies, A., Marsh, P. D., Chambers, M. A. and Hewinson, R. G. 2000. Comparison of the protective efficacy of bacille calmette-Guerin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis. Clin. Infect. Dis. 30(Suppl. 3):S299.
26. McMurray, D. N. 2001. Disease model: pulmonary tuberculosis, Trends Mol. Med. 7:135.
27. Ellner, J. J. 1997. Review: the immune response in human tuberculosis-implications for tuberculosis control. J. Infect. Dis. 176:1351.
28. Hiromatsu, K., Dascher, C. C., LeClair, K. P., Sugita, M., Furlong, S. T., Brenner, M. B. and Porcelli, S. A. 2002. Induction of CD1-restricted immune responses in guinea pigs by immunization with mycobacterial lipid antigens. J. Immunol. 169:330.
29. Hochstenbach, F., Parker, C., McLean, J., Gieselmann, V., Band, H., Bank, I., Chess, L., Spits, H., Strominger, J. L., Seidman, J. G., et al. 1988. Characterization of a third form of the human T cell receptor gamma/delta. J. Exp. Med. 168:761.
30. Blum, H., Beier, H. and Gross, H.J. 1987. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8:93.
31. Moody, D. B., Guy, M. R., Grant, E., Cheng, T. Y., Brenner, M. B., Besra, G. S. and Porcelli, S. A. 2000. CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection. J. Exp. Med. 192:965.
32. Wiegeshaus, E. H., McMurray, D. N., Grover, A. A., Harding, G. E. and Smith, D. W. 1970. Host-parasite relationships in experimental airborne tuberculosis. III. Relevance of microbial enumeration to acquired resistance in guinea pigs, Am. Rev. Respir, Dis. 102:422.
33. Smith, D. W. and Harding, G. E. 1978. Influence of BCG vaccination on bacillemic phase of experimental airborne tuberculosis in guinea pigs. In Montali, R. J., ed., Mycobacterial Infections of Zoo Animals, p. 85. Smithsonian Institution Press, Washington, DC.
34. Smith, D. W., McMurray, D. N., Wiegeshaus, E. H., Grover, A. A. and Harding, G. E. 1970. Host-parasite relationships in experimental airborne tuberculosis. IV. Early events in the course of infection in vaccinated and nonvaccinated guinea pigs. Am. Rev. Respir. Dis. 102:937.
35. Hondalus, M. K., Bardarov, S., Russell, R., Chan, J., Jacobs, W.R., Jr and Bloom, B. R. 2000. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect. Immun. 68:2888.
36. McMurray, D. N., Carlomagno, M. A. and Mintzer, C. L. 1988. Effect of diet on non-specific antimicrobial resistance in Mycobacterium bovis BCG-vaccinated guinea pigs. Nutr. Res. 8:1171.
37. Pal, P. G. and Horwitz, M. A. 1992. Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis. Infect. Immun. 60:4781.
38. Fairhurst, R. M., Wang, C. X., Sieling, P. A., Modlin, R. L. and Braun, J. 1998. CD1 presents antigens from a gram-negative bacterium, Haemophilus influenzae type B. Infect. Immun. 66:3523.
39. Lauvau, G., Vijh, S., Kong, P., Horng, T., Kerksiek, K., Serbina, N., Tuma, R. A. and Pamer, E. G. 2001. Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science 294:1735.
40. Richards, R. L., Rao, M., Wassef, N. M., Glenn, G. M., Rothwell, S. W. and Alving, C. R. 1998. Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen. Infect. Immun. 66:2859.
41. Beatty, W. L., Rhoades, E. R., Ullrich, H. J., Chatterjee, D., Heuser, J. E. and Russell, D. G. 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1:235.
42. Ilangumaran, S., Arni, S., Poincelet, M., Theler, J. M., Brennan, P. J., Nasir ud, D. and Hoessli, D. C. 1995. Integration of mycobacterial lipoarabinomannans into glycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J. Immunol. 155:1334.
43. + alpha beta T cell pool. J. Immunol. 162:366.
44. Orme, I. M., McMurray, D. N. and Belisle, J. T. 2001. Tuberculosis vaccine development: recent progress. Trends Microbiol. 9:115.